EDATE was a prospective, longitudinal, observational study conducted in 59 centres across Germany, France, Italy, and Greece, enrolling patients from November 2011 through June 2012. [20] Adult male ...

INDIANAPOLIS, Oct. 12, 2011 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) announced today that a pivotal Phase III study of Cialis® (tadalafil) tablets 5 mg for once daily use met its co-primary ...

INDIANAPOLIS, July 16, 2013 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) announced today that study results published in the Journal of Sexual Medicine showed a greater percentage of men who had ...

Discover the latest articles and news in related subjects. Coprimary efficacy measures in the base studies included mean changes from baseline to end point (or last observation carried forward [LOCF]) ...

However, EF improvement is not the only factor that is crucial to resuming a satisfying sex life. In addition to general concerns regarding efficacy or tolerability and patient or partner preference ...

Getting a prescription for tadalafil (the active ingredient in brand names Adcirca and Cialis) can be a more complicated experience than many men expect. While Cialis and its generic tadalafil are ...

Study Data Shows Cialis 5 mg Initiated with Finasteride Provides Significantly Greater Improvements in Urinary Symptoms of Benign Prostatic Hyperplasia than Placebo with Finasteride INDIANAPOLIS, Oct.

Take Cialis at least two hours before sex for the best results. Avoid heavy meals and limit alcohol before taking Cialis. Always follow your healthcare provider's prescribed dosage and don't change it ...

You might have seen Cialis — the (ED) drug — available in doses ranging from 2.5 mg to 20 mg. Surely, more is better right? Well, not always. Cialis 20 mg is an effective ED treatment, but so are the ...

Daily treatment with tadalafil may result in significantly improved erectile function in men who have an incomplete response to the maximum dose of a phosphodiesterase type 5 (PDE5) inhibitor taken as ...

Background: To explore the impact of patient-characteristics and relevant comorbidities on treatment continuation rates, effectiveness, and satisfaction in patients with erectile dysfunction (ED) who ...